U.S. market Closed. Opens in 1 day 10 hours

APLT | Applied Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue9.99MN/AN/AN/AN/AN/AN/A
Cost of Revenue353.00K441.00K415.00K380.00K23.00KN/AN/A
Gross Profit9.64M-441.00K-415.00K-380.00K-23.00KN/AN/A
Operating Expenses74.17M82.95M105.62M94.47M45.58M13.52M4.29M
Selling, General & Admin20.27M27.32M43.05M32.68M13.23M2.05M582.00K
Research & Development53.91M55.63M62.57M61.79M32.35M11.47M3.70M
Other Operating Expenses-27.00K-177.00K-521.00K-54.00K-24.00K-1.14MN/A
Operating Income-64.53M-82.95M-105.62M-94.47M-45.58M-13.52M-4.29M
Other Expenses / Income-55.23M442.00K34.00K505.00K69.00K-1.36M3.00K
Before Tax Income-119.76M-82.51M-105.58M-93.96M-45.51M-16.52M-4.28M
Income Tax ExpensesN/A-819.00K-970.00K-939.00K-116.00K4.87MN/A
Net Income-119.76M-81.69M-104.61M-93.02M-45.40M-16.52M-4.28M
Interest ExpensesN/A-442.00K555.00K559.00K93.00KN/AN/A
Basic Shares Outstanding84.24M37.83M25.60M21.97M12.83M9.16M9.16M
Diluted Shares Outstanding84.24M37.83M25.60M21.97M12.83M9.16M9.16M
EBITDA-64.18M-82.88M-105.62M-94.47M-45.58M-13.30M-4.28M
EBITDA Margin-642.27%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-119.76M-82.95M-105.03M-93.40M-45.42M-11.65M-4.28M
EBIT Margin-1,198.47%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙